Post

Experts say femtech funding booming despite wider investment downturn

The femtech sector is going from strength to strength, despite the weaker investment landscape throughout the healthcare industry, experts say. Panellists …

Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug

Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech Absci Corporation to develop an antibody therapy for an …

Q+A: Roche’s Nicole Arming and Stefano Volonté on personalised medicine’s potential

Personalised medicine is generating significant interest in the healthcare industry as standard blanket approaches to patient therapies metamorphose into individualised …

Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study

Pharmaceutical company, Qnovia has shared positive results from initial clinical trials of its prescription inhaled smoking cessation therapy. The drug delivery …

Game changing: How AI and automation is revolutionising clinical trial admin 

In the wake of COVID-19, clinical trials deserve our attention more than ever. If there’s one thing to be learned …